UNRESECTABLE BASAL CELL CARCINOMA

Clinical trials for UNRESECTABLE BASAL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE BASAL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE BASAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Dual attack: fighting cancer while protecting a transplanted kidney

Disease control Recruiting now

This study is testing a new treatment approach for people who have had a kidney transplant and now have advanced skin cancer that cannot be removed by surgery or has spread. The goal is to see if a combination of cancer immunotherapy drugs (nivolumab and ipilimumab) can be given …

Matched conditions: UNRESECTABLE BASAL CELL CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

UNRESECTABLE BASAL CELL CARCINOMA

Get alerted when new UNRESECTABLE BASAL CELL CARCINOMA trials appear

Dual attack: fighting cancer while protecting a transplanted kidney